Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management
Clinical trial NCT03591146 · COMPLETED
Trial details
- NCT number
- NCT03591146
- Sponsor
- Taiwan Liposome Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-31
- Primary completion
- 2019-01-05
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.